| |
| |
|
| Insider
Information: |
Murray Richard /ca/ |
| Relationship: |
Director |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
70,160 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$173,295 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
70,160 |
|
|
| Total
Value |
$173,295 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 34.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
EVP & CSO |
2008-07-21 |
70,159 |
2004-09-13 |
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
Director |
2023-05-03 |
1 |
2018-03-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2023-05-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(188,778) |
1 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2023-04-04 |
4 |
AS |
$1.85 |
$72,572 |
D/D |
(39,228) |
188,779 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2023-01-10 |
4 |
S |
$1.12 |
$27,864 |
D/D |
(24,879) |
228,007 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2023-01-09 |
4 |
S |
$1.10 |
$22,210 |
D/D |
(20,191) |
252,886 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
87,500 |
273,077 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2022-01-10 |
4 |
S |
$6.65 |
$159,095 |
D/D |
(23,924) |
185,577 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2022-01-07 |
4 |
S |
$7.30 |
$97,601 |
D/D |
(13,370) |
209,501 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
222,871 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
215,371 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-21 |
4 |
AS |
$12.06 |
$404,227 |
D/D |
(33,518) |
140,371 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-21 |
4 |
OE |
$0.48 |
$16,089 |
D/D |
33,518 |
173,889 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-20 |
4 |
AS |
$12.04 |
$198,443 |
D/D |
(16,482) |
140,371 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-20 |
4 |
OE |
$0.48 |
$7,911 |
D/D |
16,482 |
156,853 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-19 |
4 |
OE |
$0.48 |
$19,200 |
D/D |
40,000 |
180,371 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-19 |
4 |
AS |
$9.59 |
$383,600 |
D/D |
(40,000) |
140,371 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-15 |
4 |
AS |
$8.54 |
$256,200 |
D/D |
(30,000) |
140,371 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-15 |
4 |
OE |
$0.48 |
$14,400 |
D/D |
30,000 |
170,371 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-08 |
4 |
S |
$7.00 |
$82,712 |
D/D |
(11,816) |
140,371 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2021-01-07 |
4 |
S |
$6.76 |
$68,837 |
D/D |
(10,183) |
152,187 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
75,010 |
162,370 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2020-01-07 |
4 |
S |
$7.78 |
$55,627 |
D/D |
(7,150) |
87,360 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2019-12-23 |
4 |
OE |
$0.48 |
$19,200 |
D/D |
40,000 |
134,510 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2019-12-23 |
4 |
AS |
$8.37 |
$334,800 |
D/D |
(40,000) |
94,510 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,510 |
94,510 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
CEO and President |
• • – |
2018-09-06 |
4 |
OE |
$0.48 |
$15,360 |
D/D |
32,000 |
32,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
